Medical Biotechnology and Drug DevelopmentSemester Course

Program
Biomedicine
Week-Long Study Tour
Lisbon-Porto (Fall/Spring) or London (Spring) or Edinburgh (Fall)
Core Course Week Study Tour
Denmark
Major Discipline(s)
Biology, Biomedicine / Biotechnology, Pre-Medicine / Health Science
Type
Core Course
Available
Fall/Spring semester
Credit(s)
3

This course gives you an overview of the drug discovery and development processes where disease-targeted research leads to clinical treatments. Recent advances within medical biotechnologies and the latest treatment approaches are introduced, including stem cell technology, immunotherapies, and modern vaccines where the current “fast track” development of new SARS-CoV-2 vaccines, the virus causing COVID-19, will be considered. You will visit European pharmaceutical and biotechnology communities, university/hospital labs and start-up companies and get an insight into the business aspects of drug development and the many job niches of the field.

During Core Course Week our visits ranged from a stem cell research company to a bioinformatics company to a company that does research into lessening the burden of disease in domesticated animals. Seeing the full range of biotech companies that exist out there, and being able to compare observations about Danish biotech companies to Scottish companies was very enlightening!

Paige Arnold, Duke University

Faculty

Jeanette Erbo Wern

DIS Copenhagen Semester Faculty

Postdoc (Inst. of International Health, Immunology and Microbiology, University of Copenhagen, Denmark, 2006-2009). Ph.D. (Immunology, Inst. Of International Health, Immunology and Microbiology, University of Copenhagen, 2005).  M.Sc. (Inst. Of International Health, Immunology and Microbiology, University of Copenhagen, 2001). Senior Scientist, Immune Targeting Group, Bioneer, Copenhagen, Denmark, 2010-2013.  Senior Scientist, Dept. of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark, 2013-2016. With DIS since 2016.